Literature DB >> 21879260

Inhibition of cell motility and invasion by HangAmDan-B in NCI-H460 human non-small cell lung cancer cells.

Yong Jun Choi1, Dong Yeok Shin, Yeon-Weol Lee, Chong Kwan Cho, Gi-Young Kim, Wun-Jae Kim, Hwa Seung Yoo, Yung Hyun Choi.   

Abstract

Correlation between inhibition of cell motility and anti-invasive activity by the water extract of HangAmDan-B (HAD-B), a crude extract of eight Korean medicinal animals and plants, in NCI-H460 human non-small cell lung cancer (NSCLC) cells was investigated. Within the concentrations that were not cytotoxic, HAD-B induced significant concentration-dependent inhibition of cell motility and invasiveness of NCI-H460 cells. Treatment with HAD-B resulted in dose-dependent inhibition of the activities of matrix metallo-proteinase (MMP)-2 and MMP-9, and this was correlated with a decrease in expression of their mRNA and proteins, and upregulation of tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 expression. Anti-invasive activity of HAD-B was also found to be associated with increased tightness of the tight junction (TJ), as demonstrated by an increase in transepithelial electrical resistance. In addition, the present results indicated that treatment with HAD-B resulted in repression of the levels of claudin family members, which are major components of TJs that play a key role in control and selectivity of para-cellular transport. Although further studies are needed, findings from the present study indicate that TJs and MMPs are critical targets of HAD-B-induced anti-invasiveness in NCI-H460 NSCLC cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21879260     DOI: 10.3892/or.2011.1440

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  HangAmDan-B, an ethnomedicinal herbal mixture, suppresses inflammatory responses by inhibiting Syk/NF-κB and JNK/ATF-2 pathways.

Authors:  Tao Yu; Sang Hyun Moh; Sang-Bom Kim; Yanyan Yang; Eunji Kim; Yeon-Weol Lee; Chong-Kwan Cho; Kyung-Hee Kim; Byong Chul Yoo; Jae Youl Cho; Hwa-Seung Yoo
Journal:  J Med Food       Date:  2012-12-20       Impact factor: 2.786

2.  22-O-(N-Boc-L-glycine) ester of renieramycin M inhibits migratory activity and suppresses epithelial-mesenchymal transition in human lung cancer cells.

Authors:  Yamin Oo; Justin Quiel Lasam Nealiga; Khanit Suwanborirux; Supakarn Chamni; Gea Abigail Uy Ecoy; Varisa Pongrakhananon; Pithi Chanvorachote; Chatchai Chaotham
Journal:  J Nat Med       Date:  2021-07-21       Impact factor: 2.343

3.  Use of black vulture (Coragyps atratus) in complementary and alternative therapies for cancer in Colombia: a qualitative study.

Authors:  Ricardo Sánchez-Pedraza; Magda R Gamba-Rincón; Andrés L González-Rangel
Journal:  J Ethnobiol Ethnomed       Date:  2012-05-31       Impact factor: 2.733

4.  A Case Series of Survival Outcomes in Patients with Advanced-stage IIIb/IV Non-small-cell Lung Cancer Treated with HangAm-Plus.

Authors:  Sun-Hwi Bang; Jeung-Won Yoon; Chong-Kwan Cho; Ji-Eun Shin; Yeon-Weol Lee; Hwa-Seung Yoo
Journal:  J Pharmacopuncture       Date:  2012-06

5.  Galectin-3-independent Down-regulation of GABABR1 due to Treatment with Korean Herbal Extract HAD-B Reduces Proliferation of Human Colon Cancer Cells.

Authors:  Kyung-Hee Kim; Yong-Kyun Kwon; Chong-Kwan Cho; Yeon-Weol Lee; So-Hyun Lee; Sang-Geun Jang; Byong-Chul Yoo; Hwa-Seong Yoo
Journal:  J Pharmacopuncture       Date:  2012-09

6.  Survival Analysis of Advanced Non-Small Cell Lung Cancer Patients Treated by Using Wheel Balance Cancer Therapy.

Authors:  Jongmin Kim; Chong-Kwan Cho; Hwa-Seung Yoo
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

7.  Inhibition of lung cancer growth by HangAmDan-B is mediated by macrophage activation to M1 subtype.

Authors:  Hye-Rin Park; Eun-Ji Lee; Seong-Cheol Moon; Tae-Wook Chung; Keuk-Jun Kim; Hwa-Seung Yoo; Chong-Kwan Cho; Ki-Tae Ha
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

8.  Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell-Bearing Mice.

Authors:  Hwa Jeong Kang; Jeehye Kim; Seong Hyeok Cho; So-Jung Park; Hwa-Seung Yoo; In-Cheol Kang
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 9.  The claudin family of proteins in human malignancy: a clinical perspective.

Authors:  Lei Ding; Zhe Lu; Qun Lu; Yan-Hua Chen
Journal:  Cancer Manag Res       Date:  2013-11-08       Impact factor: 3.989

10.  Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.

Authors:  Lijuan Zhao; Shuman Li; Lin Gan; Chunhong Li; Zhu Qiu; Yixiao Feng; Jisheng Li; Lili Li; Chen Li; Weiyan Peng; Can Xu; Zhenyu Wang; Tianli Hui; Guosheng Ren; Qian Tao; Tingxiu Xiang
Journal:  J Cell Mol Med       Date:  2016-02-04       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.